Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Padra Serum Alborz is an Iranian biotechnology company specializing in the production of life-saving biological products, particularly antivenoms and vaccines. Based in the Barakat Pharmaceutical Industrial Town, the company focuses on the development and manufacturing of polyvalent serums for snake bites and scorpion stings, as well as human vaccines and plasma-derived therapeutics. As a knowledge-based enterprise, it plays a critical role in the regional supply of emergency biologics and leverages advanced purification technologies to meet international quality standards. Their portfolio includes specialized treatments for envenomation and infectious diseases, serving both domestic and international markets. The company is a key player in Iran's self-sufficiency efforts for high-tech biological medicines.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Padra Serum Alborz.